Literature DB >> 8427129

Coagulation abnormalities associated with the use of anabolic steroids.

J E Ansell1, C Tiarks, V K Fairchild.   

Abstract

According to a number of recent reports, persons using anabolic steroids may be subject to an increased risk of thromboembolism. We evaluated the effect of anabolic steroid use on the coagulation and fibrinolytic systems of 16 male bodybuilders to determine whether alterations occurred that would predispose them to a hypercoagulable state. No attempt was made to regulate or guide steroid use. Paired blood samples, both with and without steroid use, were obtained from six individuals, and the remaining subjects provided single samples obtained either during steroid use or nonuse. No differences were noted in most parameters, but we did find a significant increase in protein C antigen (p = 0.008) and free protein S antigen (p = 0.015), with a decreased euglobulin lysis time (p = 0.021) during steroid use. We also found a reduction in total cholesterol levels (p = 0.035) during steroid use. At least some of these findings suggest an activated fibrinolytic state, a known effect of anabolic steroids. The results do not support the presence of a hypercoagulable state. If anabolic steroids do produce a thrombotic tendency, they may do so through alterations in other hemostatic mechanisms or changes in lipid fractions, or more sensitive coagulation assays may be required for detection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8427129     DOI: 10.1016/0002-8703(93)90014-z

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Influence of nandrolone decanoate administration on serum lipids and liver enzymes in rats.

Authors:  Mohammad Reza Samieinasab; Mohammad Reza Shahraki; Fatemah Samieinasab; Somayeh Najafi
Journal:  ARYA Atheroscler       Date:  2015-07

2.  Validity of self-report in identifying anabolic steroid use among weightlifters.

Authors:  G S Ferenchick
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

Review 3.  Anabolic-androgenic steroids. Current issues.

Authors:  C E Yesalis; M S Bahrke
Journal:  Sports Med       Date:  1995-05       Impact factor: 11.136

4.  Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA reductase.

Authors:  Nina Gårevik; Cristine Skogastierna; Anders Rane; Lena Ekström
Journal:  Subst Abuse Treat Prev Policy       Date:  2012-03-20

Review 5.  Anabolic Androgenic Steroids: Searching New Molecular Biomarkers.

Authors:  Francesco Sessa; Monica Salerno; Giulio Di Mizio; Giuseppe Bertozzi; Giovanni Messina; Benedetta Tomaiuolo; Daniela Pisanelli; Francesca Maglietta; Pietrantonio Ricci; Cristoforo Pomara
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.